Ligand Pharmaceuticals (LGND) Cash from Operations (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Ligand Pharmaceuticals | 4.61 Bn | 3.83 Bn | 48.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.05% |
| Dec 31, 2025 | 250.76% |
| Sep 30, 2025 | -17.15% |
| Jun 30, 2025 | 162.09% |
| Mar 31, 2025 | -189.37% |
| Dec 31, 2024 | -22.06% |
| Sep 30, 2024 | 174.37% |
| Jun 30, 2024 | -28.92% |
| Mar 31, 2024 | 132.26% |
| Dec 31, 2023 | 5.48% |
| Sep 30, 2023 | 9,424.39% |
| Jun 30, 2023 | -100.24% |
| Mar 31, 2023 | -36.51% |
| Dec 31, 2022 | 160.98% |
| Sep 30, 2022 | 72.50% |
| Jun 30, 2022 | -77.16% |
| Mar 31, 2022 | 88.16% |
| Dec 31, 2021 | 38.04% |
| Sep 30, 2021 | -1.73% |
| Jun 30, 2021 | 89.48% |
| Mar 31, 2021 | 1,902.61% |
| Dec 31, 2020 | -95.79% |
| Sep 30, 2020 | -47.73% |
| Jun 30, 2020 | 44.08% |
| Mar 31, 2020 | 330.58% |
| Dec 31, 2019 | -18.43% |
| Sep 30, 2019 | -234.72% |
| Jun 30, 2019 | -89.84% |
| Mar 31, 2019 | 38.95% |
| Dec 31, 2018 | 20.27% |
| Sep 30, 2018 | -63.23% |
| Jun 30, 2018 | 21.20% |
| Mar 31, 2018 | 94.06% |
| Dec 31, 2017 | 13.24% |
| Sep 30, 2017 | 166.22% |
| Jun 30, 2017 | -45.97% |
| Mar 31, 2017 | 2.66% |
| Dec 31, 2016 | 1.09% |
| Sep 30, 2016 | 78.60% |
| Jun 30, 2016 | -20.92% |
| Mar 31, 2016 | -4.03% |
| Dec 31, 2015 | 30.93% |
| Sep 30, 2015 | 3.89% |
| Jun 30, 2015 | 32.55% |
| Mar 31, 2015 | -26.03% |
| Dec 31, 2014 | 174.32% |
| Sep 30, 2014 | -6.81% |
| Jun 30, 2014 | 55.53% |
| Mar 31, 2014 | -78.59% |
| Dec 31, 2013 | 3,452.09% |
| Sep 30, 2013 | -105.18% |
| Jun 30, 2013 | 233.83% |
| Mar 31, 2013 | 28.11% |
| Dec 31, 2012 | 389.64% |
| Sep 30, 2012 | -5.26% |
| Jun 30, 2012 | -44.17% |
| Mar 31, 2012 | -105.26% |
| Dec 31, 2011 | 765.12% |
| Sep 30, 2011 | 86.89% |
| Jun 30, 2011 | -983.10% |
| Mar 31, 2011 | 187.76% |
| Dec 31, 2010 | 86.47% |